Compare KB Financial Group, Inc. (KB) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
KB Financial Group, Inc. vs State Street SPDR S&P Biotech ETF — how do they compare? KB Financial Group, Inc. trades at $117.53 (market cap $41.21B), while State Street SPDR S&P Biotech ETF trades at $158.28. The key difference: KB Financial Group, Inc. pays a 2.67% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| KB | XBI | |
|---|---|---|
Market Cap | $41.21B | — |
Sector | Financials | Broad Market / Factor |
52-Week High | $124.01 | $164.28 |
52-Week Low | $77.50 | $86.92 |
Dividend Yield | 2.67% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About KB Financial Group, Inc.
KB Financial is the parent company of KB Kookmin Bank, Korea's largest commercial bank, with a 13.1% share of loans as of 2021. Its predecessor banks were established in the 1960s as government policy banks and privatized in the 1990s. Its credit card subsidiary KB Kookmin Card is the number-three player behind Shinhan Card and Samsung Card. KB has in recent years expanded its nonbank business by buying LIG Insurance and Hyundai Securities, making KB a top-five player in nonlife insurance and in securities, and most recently by buying Prudential Life Insurance Korea. It also has KB Capital, which provides leasing and installment finance.
Read more on KB →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
